Jevtana 60 MG/1.5 ML kit 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KC3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,854
Award facts
- Contract value 100% obligated
- $18,854.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18.85K firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of JEVTANA (60 mg/1.5 mL) kits. The contract is a non-set-aside award with a completion date of January 29, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
JEVTANA (cabazitaxel) is a chemotherapy agent used in oncology treatment, consistent with AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals supplied to federal medical institutions. As a critical pharmaceutical distributor to the Department of Defense healthcare system, AmerisourceBergen fulfills recurring medical supply needs for military treatment facilities and veteran healthcare programs. The competitive award reflects the contractor's demonstrated capability to meet federal procurement requirements for specialized pharmaceutical commodities across multiple therapeutic domains, supporting the DLA's mission to supply essential medical products to the armed forces worldwide.
Quick answers
Who was awarded contract SPE2DR26F9KC3?
SPE2DR26F9KC3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KC3 worth?
The government has obligated $18,854 on SPE2DR26F9KC3.
Is contract SPE2DR26F9KC3 an order under another contract?
Yes. SPE2DR26F9KC3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KC3 competed?
The extent of competition for SPE2DR26F9KC3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award